A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway.
Katrine HegerCaroline LundMargrete Larsen BurnsMarit BjørnvoldErik SætreSvein I JohannessenCecilie Johannessen LandmarkPublished in: Epilepsia open (2020)
The use of ASMs has changed over the last decade, in accordance with updated international recommendations. Various treatment challenges were identified. This vulnerable group of patients needs close follow-up for an optimal treatment outcome.